首页|代谢组学在过敏性紫癜诊断中的应用现状及展望

代谢组学在过敏性紫癜诊断中的应用现状及展望

扫码查看
目的 探讨代谢组学及其代谢产物在过敏性紫癜(HSP)疾病诊治中的临床意义。方法 通过文献检索,对HSP患者及动物模型的血液、尿液及粪便内代谢物质的变化及其临床意义进行了归纳总结。结果 本文共汇总出22种HSP相关差异代谢物质,包含脂类、不饱和脂肪酸、氨基酸、核苷酸及有机酸类。结论 差异性代谢产物有望成为诊断HSP及其预后分析的新型代谢标志物,此外在治疗方面,纠正代谢产物异常可能在未来成为治疗HSP的新策略。
Application Status and Prospect of Metabolomics in the Diagnosis of Henoch-Schonlein Purpura
Objective To explore the clinical significance of metabolomics and its metabolites in the diagnosis and treatment of Henoch-Schonlein purpura(HSP).Methods Through literature search,the changes of metabolites in blood,urine and feces of HSP patients and animal models and their clinical significance were summarized.Results A total of 22 HSP-related differential metabolites were summarized,including lipids,unsaturated fatty acids,amino acids,nucleotides and organic acids.Conclusions Differential metabolites are expected to become new metabolic markers for the diagnosis of HSP and its prognosis analysis.In addition,in terms of treatment,correcting metabolic abnormalities may become a new strategy for the treatment of HSP in the future.

Henoch-Schonlein purpuraDiagnosisMetabolomicsApplication statusProspect

李一凡、任献青、刘华

展开 >

河南中医药大学第一附属医院儿科医院 郑州 450000

河南中医药大学儿科医学院 郑州 450000

过敏性紫癜 诊断 代谢组学 应用现状 展望

2024

世界科学技术-中医药现代化
中科院科技政策与管理科学研究所,中国高技术产业发展促进会

世界科学技术-中医药现代化

CSTPCD北大核心
影响因子:1.175
ISSN:1674-3849
年,卷(期):2024.26(10)